- HCC-78
- HDLM-2
- DOHH-2
- L-540
- MX-1
- NALM-6
- NB-4
- CAL-51
- SNB-19
- KYSE-520
- MKN-45
- BA/F3
- MS-5
- HCEC-B4G12
- NK-92
- PA-TU-8988S
- MONO-MAC-1
- PA-TU-8902
- Human Microglia
- Human Hepatic Stellate Cells
- Human Skeletal Muscle Cells (DMD)
- Human Schwann Cells
- Human Oral Keratinocytes (HOK)
- Human Cardiomyocytes
- Human Small Intestinal Epithelial Cells
- Human Colonic Epithelial Cells
- Human Intestinal Fibroblasts
- Primary Human Large Intestine Microvascular Endothelial Cells
- Human Small Intestinal Microvascular Endothelial Cells
- Human Retinal Pigment Epithelial Cells
- Human Hepatocytes
- Cynomolgus Monkey Lung Microvascular Endothelial Cells
- Cynomolgus Monkey Vein Endothelial Cells
- C57BL/6 Mouse Primary Mammary Epithelial Cells
- C57BL/6 Mouse Vein Endothelial Cells
- Rat Primary Kidney Epithelial Cells
- Rat Gingival Epithelial Cells
- Rabbit Lung Endothelial Cells
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
Human Bone Marrow CD33+CD66+ Myeloid Cells
Cat.No.: CSC-C4618J
Species: Human
Source: Bone Marrow
Cell Type: Myeloid
- Specification
- Q & A
- Customer Review
Our CD33+ myeloid cells have been tested to have a purity of over 90% as measured by flow cytometry with a monoclonal CD33 antibody.
No, the cells will proliferate and differentiate simultaneously upon being placed in culture. Varying the cytokine cocktail can influence the differentiation and proliferation of the cells.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Excellent team of experts
A team of experts provides timely support and assist best experimental outcomes.
28 Nov 2022
Ease of use
After sales services
Value for money
Write your own review
Description: Human bone marrow stromal cells or mesenchymal stem cells (MSCs) are derived from bone marrow mononuclear cells. MSCs are isolated from a single donor. MSCs are one of the most investigated cells for therapeutic applications. These cells enable researchers to investigate stem cell properties, regenerative medicine, and tissue engineering. In addition, they may be used for developmental studies.
Development period: Postnatal
Description: Human bone marrow plasma is the liquid component of blood. Bone marrow plasma consists of dissolved proteins, glucose, clotting agents, minerals, hormones, and carbon dioxide. It makes up approximately 55% of the whole bone marrow suspension. This whole bone marrow plasma is isolated from a single donor. The plasma is separated out from the whole bone marrow (sent separately) and immediately frozen at -80°C in order to preserve its contents. Whole bone marrow plasma enables researchers to investigate specific components of bone marrow at the molecular level.
Development period: Postnatal
Description: Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are density separated by Ficoll-Paque to enrich mononuclear cells from the bone marrow. Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are available in untreated and relapsed/refractory stages.
Description: Bone Marrow is obtained from adult Myelodysplastic Syndrome patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation,the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Myelodysplastic Syndrome-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Description: Bone Marrow is obtained from adult Myelodysplastic Syndrome patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation,the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Myelodysplastic Syndrome-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages.
